Clinical trial
A Phase Two Study of ZD6474 in Patients With Relapsed Multiple Myeloma
NCT00047788 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase Two Study of ZD6474 in Patients With Relapsed Multiple Myeloma
- Lead sponsor
- Genzyme, a Sanofi Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2002
- Completion date
- May 31, 2004
- Enrollment
- 30
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.